Stocks · Health care · Pharmaceutical Preparations

RELMADA THERAPEUTICS, INC.

RLMD Clue Score50
United States Fiscal year ends December CIK 0001553643
3.39
+6.94%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
3.39 on 9 Oct 2026
8 5 2 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $2.02 14 Oct 2025 $1.93 15 Oct 2025 $2.07 16 Oct 2025 $2.01 17 Oct 2025 $2.01 20 Oct 2025 $2.26 21 Oct 2025 $2.24 22 Oct 2025 $2.14 23 Oct 2025 $2.21 24 Oct 2025 $2.10 27 Oct 2025 $2.33 28 Oct 2025 $2.45 29 Oct 2025 $2.45 30 Oct 2025 $2.32 31 Oct 2025 $2.26 3 Nov 2025 $2.20 4 Nov 2025 $2.77 5 Nov 2025 $2.51 6 Nov 2025 $2.61 7 Nov 2025 $2.65 10 Nov 2025 $3.01 11 Nov 2025 $3.29 12 Nov 2025 $3.91 13 Nov 2025 $3.88 14 Nov 2025 $3.95 17 Nov 2025 $3.97 18 Nov 2025 $4.27 19 Nov 2025 $4.18 20 Nov 2025 $4.32 21 Nov 2025 $4.27 24 Nov 2025 $4.30 25 Nov 2025 $4.26 26 Nov 2025 $4.19 28 Nov 2025 $4.51 1 Dec 2025 $4.42 2 Dec 2025 $4.04 3 Dec 2025 $4.06 4 Dec 2025 $4.00 5 Dec 2025 $4.24 8 Dec 2025 $4.17 9 Dec 2025 $4.14 10 Dec 2025 $4.42 11 Dec 2025 $4.19 12 Dec 2025 $4.06 15 Dec 2025 $4.36 16 Dec 2025 $4.50 17 Dec 2025 $4.01 18 Dec 2025 $4.15 19 Dec 2025 $4.35 22 Dec 2025 $4.49 23 Dec 2025 $4.49 24 Dec 2025 $4.60 26 Dec 2025 $4.51 29 Dec 2025 $4.45 30 Dec 2025 $4.53 31 Dec 2025 $4.83 2 Jan 2026 $4.37 5 Jan 2026 $4.23 6 Jan 2026 $4.08 7 Jan 2026 $4.32 8 Jan 2026 $4.43 9 Jan 2026 $4.31 12 Jan 2026 $4.11 13 Jan 2026 $4.06 14 Jan 2026 $3.84 15 Jan 2026 $3.80 16 Jan 2026 $3.74 20 Jan 2026 $3.94 21 Jan 2026 $3.81 22 Jan 2026 $3.96 23 Jan 2026 $3.90 26 Jan 2026 $3.97 27 Jan 2026 $4.10 28 Jan 2026 $3.95 29 Jan 2026 $3.91 30 Jan 2026 $3.55 2 Feb 2026 $3.83 3 Feb 2026 $3.80 4 Feb 2026 $3.65 5 Feb 2026 $3.60 6 Feb 2026 $3.88 9 Feb 2026 $4.20 10 Feb 2026 $4.02 11 Feb 2026 $4.00 12 Feb 2026 $3.90 13 Feb 2026 $3.72 17 Feb 2026 $3.64 18 Feb 2026 $4.08 19 Feb 2026 $4.36 20 Feb 2026 $4.13 23 Feb 2026 $4.03 24 Feb 2026 $4.26 25 Feb 2026 $4.55 26 Feb 2026 $4.60 27 Feb 2026 $4.56 2 Mar 2026 $4.84 3 Mar 2026 $4.67 4 Mar 2026 $4.77 5 Mar 2026 $4.43 6 Mar 2026 $4.45 9 Mar 2026 $7.17 10 Mar 2026 $6.62 11 Mar 2026 $6.32 12 Mar 2026 $6.15 13 Mar 2026 $5.91 16 Mar 2026 $6.18 17 Mar 2026 $6.45 18 Mar 2026 $6.21 19 Mar 2026 $6.25 20 Mar 2026 $6.07 23 Mar 2026 $5.86 24 Mar 2026 $6.10 25 Mar 2026 $6.66 26 Mar 2026 $6.53 27 Mar 2026 $6.43 30 Mar 2026 $6.38 31 Mar 2026 $6.96 1 Apr 2026 $7.10 2 Apr 2026 $6.99 6 Apr 2026 $6.90 7 Apr 2026 $6.75 8 Apr 2026 $7.01 9 Apr 2026 $7.61 10 Apr 2026 $7.29 13 Apr 2026 $7.38 14 Apr 2026 $7.19 15 Apr 2026 $7.18 16 Apr 2026 $7.00 17 Apr 2026 $7.48 20 Apr 2026 $7.37 21 Apr 2026 $7.14 22 Apr 2026 $7.06 23 Apr 2026 $7.25 24 Apr 2026 $7.21 27 Apr 2026 $7.03 28 Apr 2026 $7.24 29 Apr 2026 $7.37 30 Apr 2026 $7.52 1 May 2026 $7.64 4 May 2026 $7.41 5 May 2026 $7.35 6 May 2026 $7.86 7 May 2026 $7.43 8 May 2026 $7.32 11 May 2026 $7.36 12 May 2026 $7.45 13 May 2026 $7.49 14 May 2026 $7.42 15 May 2026 $6.90 18 May 2026 $6.34 19 May 2026 $7.03 20 May 2026 $7.17 21 May 2026 $7.21 22 May 2026 $7.04 26 May 2026 $7.17 27 May 2026 $7.26 28 May 2026 $7.25 29 May 2026 $7.21 1 Jun 2026 $6.85 2 Jun 2026 $6.42 3 Jun 2026 $6.33 4 Jun 2026 $6.31 5 Jun 2026 $5.95 8 Jun 2026 $5.72 9 Jun 2026 $6.27 10 Jun 2026 $6.38 11 Jun 2026 $6.52 12 Jun 2026 $6.65 15 Jun 2026 $6.37 16 Jun 2026 $6.55 17 Jun 2026 $6.60 18 Jun 2026 $6.73 22 Jun 2026 $6.89 23 Jun 2026 $6.77 24 Jun 2026 $6.51 25 Jun 2026 $6.45 26 Jun 2026 $6.69 29 Jun 2026 $6.98 30 Jun 2026 $6.92 1 Jul 2026 $6.39 2 Jul 2026 $6.28 6 Jul 2026 $6.33 7 Jul 2026 $6.41 8 Jul 2026 $6.41 9 Jul 2026 $6.51 10 Jul 2026 $6.41 13 Jul 2026 $6.45 14 Jul 2026 $6.21 15 Jul 2026 $6.21 16 Jul 2026 $5.46 17 Jul 2026 $5.24 20 Jul 2026 $5.00 21 Jul 2026 $5.30 22 Jul 2026 $5.00 23 Jul 2026 $5.20 24 Jul 2026 $5.18 27 Jul 2026 $5.20 28 Jul 2026 $5.23 29 Jul 2026 $5.14 30 Jul 2026 $5.35 31 Jul 2026 $5.31 3 Aug 2026 $5.30 4 Aug 2026 $5.47 5 Aug 2026 $5.44 6 Aug 2026 $5.37 7 Aug 2026 $4.94 10 Aug 2026 $4.54 11 Aug 2026 $4.47 12 Aug 2026 $4.72 13 Aug 2026 $4.75 14 Aug 2026 $4.80 17 Aug 2026 $4.77 18 Aug 2026 $4.85 19 Aug 2026 $4.83 20 Aug 2026 $4.64 21 Aug 2026 $4.63 24 Aug 2026 $4.58 25 Aug 2026 $4.59 26 Aug 2026 $4.55 27 Aug 2026 $4.52 28 Aug 2026 $4.33 31 Aug 2026 $4.36 1 Sep 2026 $4.46 2 Sep 2026 $4.54 3 Sep 2026 $4.37 4 Sep 2026 $4.43 8 Sep 2026 $4.25 9 Sep 2026 $4.09 10 Sep 2026 $4.07 11 Sep 2026 $4.52 14 Sep 2026 $4.44 15 Sep 2026 $4.44 16 Sep 2026 $4.22 17 Sep 2026 $4.20 18 Sep 2026 $4.12 21 Sep 2026 $4.16 22 Sep 2026 $4.24 23 Sep 2026 $3.78 24 Sep 2026 $3.81 25 Sep 2026 $3.83 28 Sep 2026 $3.79 29 Sep 2026 $3.73 30 Sep 2026 $3.77 1 Oct 2026 $3.66 2 Oct 2026 $3.60 5 Oct 2026 $3.48 6 Oct 2026 $3.28 7 Oct 2026 $3.25 8 Oct 2026 $3.17 9 Oct 2026 $3.39 Kelly Paul Edward Chief Operating Officer Bought $198.00K 5 Nov 2025 · at $2.20 · 21.8% of stake Ence Chuck CAO and COO Bought $299.20K 5 Nov 2025 · at $2.20 · 50.8% of stake TRAVERSA SERGIO Chief Executive Officer Bought $599.50K 5 Nov 2025 · at $2.20 · 27.3% of stake Shenouda Maged Chief Financial Officer Bought $1.10M 5 Nov 2025 · at $2.20 · 173% of stake Shenouda Maged Chief Financial Officer Bought $48.06K 15 Dec 2025 · at $4.12 · 1.5% of stake TRAVERSA SERGIO Chief Executive Officer Bought $113.30K 15 Dec 2025 · at $4.12 · 2.2% of stake TRAVERSA SERGIO Chief Executive Officer Bought $418.00K 9 Sep 2026 · at $4.18 · 7.7% of stake Shenouda Maged Chief Financial Officer Bought $504.84K 9 Sep 2026 · at $4.20 · 15.0% of stake Shenouda Maged Chief Financial Officer Bought $339.15K 10 Sep 2026 · at $4.25 · 8.7% of stake TRAVERSA SERGIO Chief Executive Officer Bought $410.00K 10 Sep 2026 · at $4.10 · 7.1% of stake
10 buys0 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$57.39M
Free cash flow
$45.79M
Return on equity
-66.3%
Return on capital
-54.0%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -59M FY20 Fiscal year 2020 Revenue $0.00 Net income $59.46M Margin n/a 0K -126M FY21 Fiscal year 2021 Revenue $0.00 Net income $125.75M Margin n/a 0K -157M FY22 Fiscal year 2022 Revenue $0.00 Net income $157.04M Margin n/a 0K -99M FY23 Fiscal year 2023 Revenue $0.00 Net income $98.79M Margin n/a 0K -80M FY24 Fiscal year 2024 Revenue $0.00 Net income $79.98M Margin n/a 0K -57M FY25 Fiscal year 2025 Revenue $0.00 Net income $57.39M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
10 Sep 2026 TRAVERSA SERGIO
Chief Executive Officer
Bought $410.00K 7.1%
10 Sep 2026 Shenouda Maged
Chief Financial Officer
Bought $339.15K 8.7%
9 Sep 2026 Shenouda Maged
Chief Financial Officer
Bought $504.84K 15.0%
9 Sep 2026 TRAVERSA SERGIO
Chief Executive Officer
Bought $418.00K 7.7%
15 Dec 2025 TRAVERSA SERGIO
Chief Executive Officer
Bought $113.30K 2.2%
15 Dec 2025 Shenouda Maged
Chief Financial Officer
Bought $48.06K 1.5%